Modulation of synaptic phosphodiesterase PDE2A activity is a new therapeutic approach for Fragile X Syndrome in newborns and adolescents.
Ontology highlight
ABSTRACT: FMR1 HITS-CLIP experiments of mice cerebellum, cortex and Hypocamppi
ORGANISM(S): Mus musculus
PROVIDER: GSE104269 | GEO | 2018/03/28
REPOSITORIES: GEO
ACCESS DATA